Harnessing the principle that allows blood to clot, researchers work on new synthetic materials to plug holes

January 9, 2013 by David L. Chandler
The first stage of blood clotting is the formation of a plug, seen here, which is made up of platelets (seen in gold) and structures called von Willebrand Factor (vWF), seen in red. The vWF structures are normally present in blood in coiled up form, but in the presence of the flow from a bleeding wound they unfurl to form long, sticky strands, which bind the platelets together. Credit: Hsieh Chen

When you get a cut, blood starts to flow from the wound. But very quickly, complex biochemical processes spring into action, creating a scaffolding of molecules to block the hole, and then building up an impervious clot to stanch the flow.

That process relies on a set of molecules that constantly flow through the body's , just waiting to spring into action when needed. When their job is done, they dissolve back into the blood, awaiting their next repair job.

A team of MIT researchers has analyzed the process and found, for the first time, exactly how the different work together to block the flow of blood from a cut. Now, they are working on applying that knowledge to the development of that could be used to control different kinds of liquid flows, and could lead to a variety of new self-assembling materials.

The research is published this week in the online journal Nature Communications, in a paper co-authored by MIT assistant professor of Alfredo Alexander-Katz, graduate student Hsieh Chen, and six other researchers in the United States, Germany and Austria.

One of the surprising things the team found out is that the increased caused by a wound automatically triggers the reaction that plugs the hole: The faster the flow, the more effectively it works. That's a counterintuitive finding, since faster flows usually stir things up rather than causing them to clump together.

The video will load shortly

The way the molecules in the react to a leak "is something very freaky," Alexander-Katz says. "Part of it is chemistry, and part of it is mechanical, which has to do with the flow itself."

The key molecule, he explains, is a —a long, chainlike structure—called the von Willebrand factor (vWF), named for a disease in which it is suppressed in the bloodstream. This molecule normally flows through the bloodstream in a rolled-up form in which it is essentially inactive.

However, "as soon as you stretch [vWFs], they become sticky," Alexander-Katz says. He compares the reaction to a roll of adhesive tape: It's only when you pull the tape out from the roll that the sticky part is exposed and begins to attach to things. In the case of these molecules in the blood, in an increased rate of flow, he says, "you stretch them out, and they become sticky and begin sticking to platelets." The vWFs begin to form a network over the cut—a mixture of the sticky molecules and platelets—that forms a plug within seconds. Over time, additional cells accumulate to form a clot.

If this process were uncontrolled, such plugs would form constantly in the bloodstream, Alexander-Katz says. To counteract that, another kind of molecule also circulates: a kind of "molecular scissors," he says, that "comes around and cuts [the plugs] to pieces."

Most of the time, the clumping and snipping remain in balance, so no clots form. But when the flow rate increases, the vWF stretch and grow stickier, and the "molecular scissors" can't keep up—so the plug builds up.

One reason this process interests materials scientists is that most biochemical materials, such as shells or bones, form extremely slowly. But clotting takes place rapidly—so these insights could lead to solid structural materials that can form quickly.

The flow-induced clumping, the team writes in its report, is "a completely new aggregation paradigm." Alexander-Katz says that this process "seems to be a transition [from one chemical state to another] that hasn't been studied before," as well as a universal behavior that depends primarily on the shapes of polymers and particles.

What's more, the process is reversible: When the flow rate slows down, the plugs disaggregate anew. By selecting different polymer building blocks, it's possible to "tune" the material to clump up at any specific flow-rate, he says.

"I think we can start making all kinds of different aggregates that depend on flow conditions," Alexander-Katz says. There may be a number of possible applications for inks, pigments and coatings, he suggests, or for devices such as self-healing tires. "There are so many processes where you have flows," he says.

Evan Sadler, a professor of medicine and of biochemistry and molecular biophysics at Washington University in St. Louis, says, "I find it fascinating that a relatively simple model may account for the behavior of platelets and von Willebrand factor in flowing blood." He adds that all animals have this factor, and all have platelets, but the sizes of platelets and the rates of blood flow vary greatly. This work, he says, "may help us to understand how the binding characteristics of vWF and platelets have been tuned by evolution to maintain normal hemostatic function across such a large range of conditions."

Explore further: Exploring the molecular origin of blood clot flexibility

Related Stories

Exploring the molecular origin of blood clot flexibility

January 12, 2007

How do blood clots maintain that precise balance of stiffness for wound healing and flexibility to go with the flow? Researchers at the University of Pennsylvania School of Medicine and the School of Arts and Sciences have ...

Evolution provides clue to blood clotting

July 20, 2011

A simple cut to the skin unleashes a complex cascade of chemistry to stem the flow of blood. Now, scientists at Washington University School of Medicine in St. Louis have used evolutionary clues to reveal how a key clotting ...

Chemists unlock potential target for drug development

January 19, 2012

A receptor found on blood platelets whose importance as a potential pharmaceutical target has long been questioned may in fact be fruitful in drug testing, according to new research from Michigan State University chemists.

Recommended for you

Isolation of Fe(IV) decamethylferrocene salts

August 29, 2016

(Phys.org)—Ferrocene is the model compound that students often learn when they are introduced to organometallic chemistry. It has an iron center that is coordinated to the π electrons in two cyclopentadienyl rings. (C5H5- ...

Bringing artificial enzymes closer to nature

August 29, 2016

Scientists at the University of Basel, ETH Zurich, and NCCR Molecular Systems Engineering have developed an artificial metalloenzyme that catalyses a reaction inside of cells without equivalent in nature. This could be a ...

New method developed for producing some metals

August 25, 2016

The MIT researchers were trying to develop a new battery, but it didn't work out that way. Instead, thanks to an unexpected finding in their lab tests, what they discovered was a whole new way of producing the metal antimony—and ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.